Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johann Sellner

Showing results (1-10 of 174) with videos related to

Pageof 18
Sort By:
Journal of Neurosciences in Rural Practice|August 6, 2013
CommentaryJohann Sellner
Wiener Medizinische Wochenschrift (1946)|October 26, 2022
Multiple sclerosis at the crossroads of scientific evidence and clinical translationJohann Sellner
Wiener Medizinische Wochenschrift (1946)|November 3, 2023
Autoimmune neurology-a rapidly evolving fieldJohann Sellner
Journal of Central Nervous System Disease|October 24, 2022
Natalizumab extended-interval dosing in multiple sclerosis to mitigate progressive multifocal leukoencephalopathy risk: initial study evidence and real-world experienceJulian Perncezky, Johann Sellner
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|April 8, 2009
European teaching course on autonomic nervous system disorders : reaching out to young physiciansWalter Struhal, Johann Sellner,
Drug Discovery Today|November 28, 2020
Second-generation immunotherapeutics in multiple sclerosis: can we discard their precursors?Oliver Findling, Johann Sellner
Drug Design, Development and Therapy|November 17, 2022
Diroximel Fumarate as a Novel Oral Immunomodulating Therapy for Relapsing Forms of Multiple Sclerosis: A Review on the Emerging DataLarissa Hauer, Johann Sellner
Journal of Neurology|April 25, 2012
Seizures and epilepsy in herpes simplex virus encephalitis: current concepts and future directions of pathogenesis and managementJohann Sellner, Eugen Trinka
Neurology|June 1, 2016
Journal Club: Effect of comorbidity on mortality in multiple sclerosisAnush Karamyan, Johann Sellner
Handbook of Clinical Neurology|July 13, 2014
Neurologic complications of hepatic virusesJohann Sellner, Israel Steiner
Pageof 18

Showing results (1-10 of 174) with videos related to

Sort By:
Pageof 18
Journal of Neurosciences in Rural Practice|August 6, 2013
CommentaryJohann Sellner
Wiener Medizinische Wochenschrift (1946)|October 26, 2022
Multiple sclerosis at the crossroads of scientific evidence and clinical translationJohann Sellner
Wiener Medizinische Wochenschrift (1946)|November 3, 2023
Autoimmune neurology-a rapidly evolving fieldJohann Sellner
Journal of Central Nervous System Disease|October 24, 2022
Natalizumab extended-interval dosing in multiple sclerosis to mitigate progressive multifocal leukoencephalopathy risk: initial study evidence and real-world experienceJulian Perncezky, Johann Sellner
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|April 8, 2009
European teaching course on autonomic nervous system disorders : reaching out to young physiciansWalter Struhal, Johann Sellner,
Drug Discovery Today|November 28, 2020
Second-generation immunotherapeutics in multiple sclerosis: can we discard their precursors?Oliver Findling, Johann Sellner
Drug Design, Development and Therapy|November 17, 2022
Diroximel Fumarate as a Novel Oral Immunomodulating Therapy for Relapsing Forms of Multiple Sclerosis: A Review on the Emerging DataLarissa Hauer, Johann Sellner
Journal of Neurology|April 25, 2012
Seizures and epilepsy in herpes simplex virus encephalitis: current concepts and future directions of pathogenesis and managementJohann Sellner, Eugen Trinka
Neurology|June 1, 2016
Journal Club: Effect of comorbidity on mortality in multiple sclerosisAnush Karamyan, Johann Sellner
Handbook of Clinical Neurology|July 13, 2014
Neurologic complications of hepatic virusesJohann Sellner, Israel Steiner
Pageof 18